PortalPublikationenA Prospective Study on the Impact and Out-of-Pocket Costs of...

A Prospective Study on the Impact and Out-of-Pocket Costs of Dengue Illness in International Travelers.

Standard

A Prospective Study on the Impact and Out-of-Pocket Costs of Dengue Illness in International Travelers. / Tozan, Y; Headley, TY; Sewe, MO; Schwartz, E; Shemesh, T; Cramer, JP; Eberhardt, KA; Ramharter, M; Harrison, N; Leder, K; Angheben, A; Hatz, C; Switzerland, Swiss Tropical and Public Health Institute; Chen, Lin Hwei; De Pijper, Cornelis A; Grobusch, Martin P; Wilder-Smith, A.

in: AM J TROP MED HYG, Jahrgang 100, Nr. 6, 06.2019, S. 1525-1533.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Tozan, Y, Headley, TY, Sewe, MO, Schwartz, E, Shemesh, T, Cramer, JP, Eberhardt, KA, Ramharter, M, Harrison, N, Leder, K, Angheben, A, Hatz, C, Switzerland, STAPHI, Chen, LH, De Pijper, CA, Grobusch, MP & Wilder-Smith, A 2019, 'A Prospective Study on the Impact and Out-of-Pocket Costs of Dengue Illness in International Travelers.', AM J TROP MED HYG, Jg. 100, Nr. 6, S. 1525-1533. https://doi.org/10.4269/ajtmh.18-0780

APA

Tozan, Y., Headley, TY., Sewe, MO., Schwartz, E., Shemesh, T., Cramer, JP., Eberhardt, KA., Ramharter, M., Harrison, N., Leder, K., Angheben, A., Hatz, C., Switzerland, S. T. A. P. H. I., Chen, L. H., De Pijper, C. A., Grobusch, M. P., & Wilder-Smith, A. (2019). A Prospective Study on the Impact and Out-of-Pocket Costs of Dengue Illness in International Travelers. AM J TROP MED HYG, 100(6), 1525-1533. https://doi.org/10.4269/ajtmh.18-0780

Vancouver

Tozan Y, Headley TY, Sewe MO, Schwartz E, Shemesh T, Cramer JP et al. A Prospective Study on the Impact and Out-of-Pocket Costs of Dengue Illness in International Travelers. AM J TROP MED HYG. 2019 Jun;100(6):1525-1533. https://doi.org/10.4269/ajtmh.18-0780

Bibtex

@article{77103837fa86406db2b5d18894d69823,
title = "A Prospective Study on the Impact and Out-of-Pocket Costs of Dengue Illness in International Travelers.",
abstract = "Although the costs of dengue illness to patients and households have been extensively studied in endemic populations, international travelers have not been the focus of costing studies. As globalization and human travel activities intensify, travelers are increasingly at risk for emerging and reemerging infectious diseases, such as dengue. This exploratory study aims to investigate the impact and out-of-pocket costs of dengue illness among travelers. We conducted a prospective study in adult travelers with laboratory-confirmed dengue and recruited patients at travel medicine clinics in eight different countries from December 2013 to December 2015. Using a structured questionnaire, we collected information on patients and their health-care utilization and out-of-pocket expenditures, as well as income and other financial losses they incurred because of dengue illness. A total of 90 patients participated in the study, most of whom traveled for tourism (74%) and visited countries in Asia (82%). Although 22% reported hospitalization and 32% receiving ambulatory care while traveling, these percentages were higher at 39% and 71%, respectively, after returning home. The out-of-pocket direct and indirect costs of dengue illness were US$421 (SD 744) and US$571 (SD 1,913) per episode, respectively, averaging to a total out-of-pocket cost of US$992 (SD 2,052) per episode. The study findings suggest that international travelers incur important direct and indirect costs because of dengue-related illness. This study is the first to date to investigate the impact and out-of-pocket costs of travel-related dengue illness from the patient's perspective and paves the way for future economic burden studies in this population.",
author = "Y Tozan and TY Headley and MO Sewe and E Schwartz and T Shemesh and JP Cramer and KA Eberhardt and M Ramharter and N Harrison and K Leder and A Angheben and C Hatz and Switzerland, {Swiss Tropical and Public Health Institute} and Chen, {Lin Hwei} and {De Pijper}, {Cornelis A} and Grobusch, {Martin P} and A Wilder-Smith",
year = "2019",
month = jun,
doi = "10.4269/ajtmh.18-0780",
language = "English",
volume = "100",
pages = "1525--1533",
journal = "AM J TROP MED HYG",
issn = "0002-9637",
publisher = "American Society of Tropical Medicine and Hygiene",
number = "6",

}

RIS

TY - JOUR

T1 - A Prospective Study on the Impact and Out-of-Pocket Costs of Dengue Illness in International Travelers.

AU - Tozan, Y

AU - Headley, TY

AU - Sewe, MO

AU - Schwartz, E

AU - Shemesh, T

AU - Cramer, JP

AU - Eberhardt, KA

AU - Ramharter, M

AU - Harrison, N

AU - Leder, K

AU - Angheben, A

AU - Hatz, C

AU - Switzerland, Swiss Tropical and Public Health Institute

AU - Chen, Lin Hwei

AU - De Pijper, Cornelis A

AU - Grobusch, Martin P

AU - Wilder-Smith, A

PY - 2019/6

Y1 - 2019/6

N2 - Although the costs of dengue illness to patients and households have been extensively studied in endemic populations, international travelers have not been the focus of costing studies. As globalization and human travel activities intensify, travelers are increasingly at risk for emerging and reemerging infectious diseases, such as dengue. This exploratory study aims to investigate the impact and out-of-pocket costs of dengue illness among travelers. We conducted a prospective study in adult travelers with laboratory-confirmed dengue and recruited patients at travel medicine clinics in eight different countries from December 2013 to December 2015. Using a structured questionnaire, we collected information on patients and their health-care utilization and out-of-pocket expenditures, as well as income and other financial losses they incurred because of dengue illness. A total of 90 patients participated in the study, most of whom traveled for tourism (74%) and visited countries in Asia (82%). Although 22% reported hospitalization and 32% receiving ambulatory care while traveling, these percentages were higher at 39% and 71%, respectively, after returning home. The out-of-pocket direct and indirect costs of dengue illness were US$421 (SD 744) and US$571 (SD 1,913) per episode, respectively, averaging to a total out-of-pocket cost of US$992 (SD 2,052) per episode. The study findings suggest that international travelers incur important direct and indirect costs because of dengue-related illness. This study is the first to date to investigate the impact and out-of-pocket costs of travel-related dengue illness from the patient's perspective and paves the way for future economic burden studies in this population.

AB - Although the costs of dengue illness to patients and households have been extensively studied in endemic populations, international travelers have not been the focus of costing studies. As globalization and human travel activities intensify, travelers are increasingly at risk for emerging and reemerging infectious diseases, such as dengue. This exploratory study aims to investigate the impact and out-of-pocket costs of dengue illness among travelers. We conducted a prospective study in adult travelers with laboratory-confirmed dengue and recruited patients at travel medicine clinics in eight different countries from December 2013 to December 2015. Using a structured questionnaire, we collected information on patients and their health-care utilization and out-of-pocket expenditures, as well as income and other financial losses they incurred because of dengue illness. A total of 90 patients participated in the study, most of whom traveled for tourism (74%) and visited countries in Asia (82%). Although 22% reported hospitalization and 32% receiving ambulatory care while traveling, these percentages were higher at 39% and 71%, respectively, after returning home. The out-of-pocket direct and indirect costs of dengue illness were US$421 (SD 744) and US$571 (SD 1,913) per episode, respectively, averaging to a total out-of-pocket cost of US$992 (SD 2,052) per episode. The study findings suggest that international travelers incur important direct and indirect costs because of dengue-related illness. This study is the first to date to investigate the impact and out-of-pocket costs of travel-related dengue illness from the patient's perspective and paves the way for future economic burden studies in this population.

UR - http://europepmc.org/abstract/med/30994088

U2 - 10.4269/ajtmh.18-0780

DO - 10.4269/ajtmh.18-0780

M3 - SCORING: Journal article

C2 - 30994088

VL - 100

SP - 1525

EP - 1533

JO - AM J TROP MED HYG

JF - AM J TROP MED HYG

SN - 0002-9637

IS - 6

ER -